Variant report

Variant	rs2257131
Chromosome Location	chr15:33418575-33418576
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr15:33359725..33362566-chr15:33418039..33421001,3	MCF-7	breast:

Variant related genes	Relation type
ENSG00000248905	Chromatin interaction

Extended variants
information (count: 40 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:33)

rs_ID	r²[population]
rs1454987	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs1902148	0.91[ASN][1000 genomes]
rs2085180	0.96[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];1.00[AMR][1000 genomes];0.85[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2085181	0.84[AFR][1000 genomes];1.00[AMR][1000 genomes];0.85[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2444953	0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2444956	0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2444960	0.94[AFR][1000 genomes];0.99[AMR][1000 genomes];0.84[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2444962	0.91[CHB][hapmap];0.86[JPT][hapmap];0.86[ASN][1000 genomes]
rs2444964	0.86[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2444965	0.86[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2444966	0.86[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2444967	0.86[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2444969	0.86[ASN][1000 genomes]
rs2444970	0.80[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2444972	0.86[ASN][1000 genomes]
rs2444973	0.86[ASN][1000 genomes]
rs2444974	0.86[ASN][1000 genomes]
rs2444975	0.86[ASN][1000 genomes]
rs2444976	0.84[ASN][1000 genomes]
rs2444979	0.82[ASN][1000 genomes]
rs2468741	0.83[CEU][hapmap];1.00[CHB][hapmap];0.96[JPT][hapmap];1.00[YRI][hapmap]
rs2468746	0.88[AMR][1000 genomes];0.90[ASN][1000 genomes]
rs2468748	0.86[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2468749	0.85[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2468750	0.86[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2468751	0.81[ASN][1000 genomes]
rs2468752	0.80[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs2468755	0.86[ASN][1000 genomes]
rs2468756	0.83[ASN][1000 genomes]
rs345759	0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs345762	0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs3861197	0.89[ASN][1000 genomes]
rs4780082	0.95[CHB][hapmap];0.86[JPT][hapmap];0.89[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv903979	chr15:33144202-33550256	Active TSS Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
2	nsv1052966	chr15:33149753-33541951	Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
3	nsv542340	chr15:33149753-33541951	Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Genic enhancers Bivalent Enhancer Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
4	nsv903981	chr15:33207082-33550256	Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
5	nsv568918	chr15:33244672-33446971	Enhancers Flanking Active TSS ZNF genes & repeats Weak transcription Genic enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
6	nsv903982	chr15:33282844-33616150	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
7	nsv903983	chr15:33388030-33550256	Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:87 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:33411800-33420200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr15:33414600-33419200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
3	chr15:33416200-33419000	Enhancers	HSMMtube	muscle
4	chr15:33416600-33420400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
5	chr15:33416800-33418800	Enhancers	Muscle Satellite Cultured Cells	--
6	chr15:33417000-33418600	Enhancers	Primary T killer memory cells from peripheral blood	blood
7	chr15:33417200-33419600	Enhancers	Primary T helper naive cells from peripheral blood	blood
8	chr15:33417400-33420200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
9	chr15:33417800-33419200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr15:33417800-33419400	Enhancers	Primary T cells fromperipheralblood	blood
11	chr15:33417800-33419600	Enhancers	Primary hematopoietic stem cells	blood
12	chr15:33418000-33418600	Enhancers	HSMM	muscle
13	chr15:33418000-33418600	Enhancers	HUVEC	blood vessel
14	chr15:33418000-33418600	Enhancers	Monocytes-CD14+_RO01746	blood
15	chr15:33418000-33418800	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
16	chr15:33418000-33419200	Enhancers	Pancreatic Islets	Pancreatic Islet
17	chr15:33418000-33419400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr15:33418000-33419600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr15:33418000-33420200	Enhancers	Primary hematopoietic stem cells short term culture	blood
20	chr15:33418200-33418600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr15:33418200-33418600	Enhancers	Rectal Mucosa Donor 29	rectum
22	chr15:33418200-33418800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
23	chr15:33418200-33418800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
24	chr15:33418200-33418800	Enhancers	Osteobl	bone
25	chr15:33418200-33419000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr15:33418200-33419000	Flanking Active TSS	Primary T cells from cord blood	blood
27	chr15:33418200-33419000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
28	chr15:33418200-33419200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
29	chr15:33418200-33419200	Enhancers	Primary B cells from peripheral blood	blood
30	chr15:33418200-33419200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr15:33418200-33419400	Enhancers	Cortex derived primary cultured neurospheres	brain
32	chr15:33418200-33419400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr15:33418200-33419400	Enhancers	Spleen	Spleen
34	chr15:33418200-33419600	Enhancers	Rectal Mucosa Donor 31	rectum
35	chr15:33418200-33419800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
36	chr15:33418200-33419800	Enhancers	HMEC	breast
37	chr15:33418200-33420000	Enhancers	Fetal Muscle Leg	muscle
38	chr15:33418200-33420200	Enhancers	Primary monocytes fromperipheralblood	blood
39	chr15:33418200-33420600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr15:33418400-33418600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr15:33418400-33418600	Flanking Active TSS	Hela-S3	cervix
42	chr15:33418400-33418800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr15:33418400-33418800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr15:33418400-33418800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr15:33418400-33418800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr15:33418400-33418800	Enhancers	Adipose Nuclei	Adipose
47	chr15:33418400-33418800	Enhancers	Brain Cingulate Gyrus	brain
48	chr15:33418400-33418800	Active TSS	Colonic Mucosa	Colon
49	chr15:33418400-33418800	Enhancers	Duodenum Mucosa	Duodenum
50	chr15:33418400-33418800	Enhancers	Esophagus	oesophagus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links